Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

H7N9 mutation could reduce vaccine effectiveness - study
H7N9 viruses are currently circulating in poultry populations in China and have so far caused more than 1,600 human cases.
Scientists shed new light on H7N9 viruses in China 

Pirbright scientists have identified a mutation in the H7N9 avian influenza virus that could allow it to escape immune system defences, reducing the effectiveness of vaccines.

H7N9 viruses are currently circulating in poultry populations in China and have so far caused more than 1,600 human cases - over 600 of which have been fatal.

Research published in the Journal of Virology shows that small genetic differences in the virus surface proteins can stop antibodies that protect against a low pathogenic form of the virus from binding to a more virulent form.

This protein, called haemagglutinin, enables the first stage of infection, where the virus attaches to cells and initiates entry into them. Antibodies that bind to the haemagglutinin prevent this process, thereby protecting against infection.

Professor Munir Iqbal, head of the avian influenza group at Pirbright, said: “We discovered that a single amino acid substitution on the H7N9 haemagglutinin, changes its structure enough to reduce antibody binding levels between the two pathotypes.

“This suggests that a single vaccine might not be able to protect against both low and high pathogenicity H7N9 viruses if they carry different amino acid residues at the identified site, stressing the importance of continually monitoring outbreak strains for genetic changes in this region.”

The research team also found that antibodies produced against the high pathogenicity virus showed strong cross-reactivity to both the high and low pathogenicity viruses, compared to those produced against the low pathogenicity virus.

Scientists said this suggests vaccines developed from high pathogenicity strains may be better vaccine candidates for protecting poultry and humans in China. Further research is needed to understand the effect of genetic variations at the site researchers identified in the haemagglutinin.

 

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
Milk recalled over presence of veterinary medicines

Graham's Family Dairy has issued a recall for its semi-skimmed milk due to the presence of veterinary medicines in the product.

In a risk statement, the Food Standards Agency said the presence of the medicines, including penicillin, make the milk unsafe to consume and 'may be a possible health risk for anyone with an allergy to antibiotics'.

Customers who bought the product are advised to return it to the store of purchase for a full refund.